128437-99-0 Usage
Description
(4-Benzyloxy)pyruvic Acid, also known as benzyl 4-hydroxy-3-oxobutanoate, is a chemical compound that belongs to the class of organic compounds known as phenylpyruvic acids. It is a white to off-white crystalline powder that is slightly soluble in water and soluble in organic solvents. (4-Benzyloxy)pyruvic Acid is known for its potential biological activity and has been studied for its potential applications in the pharmaceutical industry.
Uses
Used in Pharmaceutical Industry:
(4-Benzyloxy)pyruvic Acid is used as an intermediate in the synthesis of pharmaceuticals for its potential biological activity. It plays a crucial role in the development of new drugs and organic products, contributing to the advancement of medical treatments.
Used in Flavor and Fragrance Production:
(4-Benzyloxy)pyruvic Acid is used as a component in the production of flavors and fragrances, adding unique scents and tastes to various consumer products. Its presence in these products enhances the sensory experience for users.
Further Research:
(4-Benzyloxy)pyruvic Acid is a compound of interest for its potential applications in the pharmaceutical industry. However, further research is needed to fully understand its properties and potential uses, ensuring that it can be effectively and safely utilized in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 128437-99-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,4,3 and 7 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 128437-99:
(8*1)+(7*2)+(6*8)+(5*4)+(4*3)+(3*7)+(2*9)+(1*9)=150
150 % 10 = 0
So 128437-99-0 is a valid CAS Registry Number.
128437-99-0Relevant articles and documents
SELECTED CGRP ANTAGONISTS, METHODS FOR THE PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS
-
Page/Page column 227, (2008/06/13)
The invention relates to CGRP antagonists of general formula (I), in which A, X, D, E, G, M, Q and R1 to R3 are defined as in Claim 1, to their tautomers, isomers, diastereomers, enantiomers, hydrates, mixtures and their salts as well as the hydrates of the salts, particularly their physiologically compatible salts having inorganic or organic acids, to medicaments containing these compounds, to their use, and to methods for the production thereof.
